DHBUD
Delivra Health Brands Inc., through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide. The company offers cannabis, liquid sleep shots, sleep powder packets, gummies, and pain relief creams. It sells its products under LivRelief, Dream Water, and LivRelief infused brands. The company was formerly known as Harvest One Cannabis Inc. Delivra Heal… Read more
Market Cap & Net Worth: DHBUD (DHBUD)
DHBUD (OTCQB:DHBUD) has a market capitalization of $1.17K ($1.17K) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #47915 globally and #14759 in its home market, demonstrating a -5.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying DHBUD's stock price $0.12 by its total outstanding shares 9509 (9.51K).
DHBUD Market Cap History: 2025 to 2025
DHBUD's market capitalization history from 2025 to 2025. Data shows growth from $1.17K to $1.17K (0.00% CAGR).
DHBUD Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how DHBUD's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of DHBUD by Market Capitalization
Companies near DHBUD in the global market cap rankings as of March 19, 2026.
Key companies related to DHBUD by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
DHBUD Historical Marketcap From 2025 to 2025
Between 2025 and today, DHBUD's market cap moved from $1.17K to $ 1.17K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $1.17K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of DHBUD was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.17K USD |
| MoneyControl | $1.17K USD |
| MarketWatch | $1.17K USD |
| marketcap.company | $1.17K USD |
| Reuters | $1.17K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.